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Abstract: DNA shape readout is an important mechanism of transcription factor target site 
recognition, in addition to the sequence readout. Several machine learning-based models of 
transcription factor–DNA interactions, considering DNA shape features, have been developed in 
recent years. Here, we present a new biophysical model of protein–DNA interactions by 
integrating the DNA shape properties. It is based on the neighbor dinucleotide dependency model 
BayesPI2, where new parameters are restricted to a subspace spanned by the dinucleotide form of 
DNA shape features. This allows a biophysical interpretation of the new parameters as a 
position-dependent preference towards specific DNA shape features. Using the new model, we 
explore the variation of DNA shape preferences in several transcription factors across various 
cancer cell lines and cellular conditions. The results reveal that there are DNA shape variations at 
FOXA1 (Forkhead Box Protein A1) binding sites in steroid-treated MCF7 cells. The new biophysical 
model is useful for elucidating the finer details of transcription factor–DNA interaction, as well as 
for predicting cancer mutation effects in the future. 
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1. Introduction 
Understanding how transcription factors (TFs) recognize their target DNA binding sites is an 
important task in the study of gene regulation. Although a complete model of this process is 
currently out of reach [1], the growing body of experimental data enables the development of many 
approximate models to compute TF–DNA binding affinity. There are models that aim at identifying 
proteins that may bind to DNA based on the protein amino acid sequences (e.g., nDNA-Prot [2]) or 
models that focus on the prediction of protein target sites (e.g., BayesPI2 [3]). The latter ones are 
useful in identifying functional TF binding sites, predicting the effects of mutations on gene 
regulation [4], and elucidating the differences between related TFs [5]. Current approaches to 
estimate the TF–DNA binding affinity can be broadly divided into two categories: one is the “black 
box” approach, which uses powerful machine learning techniques (e.g., support vector machines, 
random forest, neural network or ensemble methods such as LibD3C [6]) with as many input 
features as possible, to achieve the most accurate affinity predictions [7–10]; and the other is the 
biophysical modeling approach, which derives physical models from first principles by using 
well-understood approximations in statistical physics [11–13]. Generally, machine learning methods 
have high accuracy after considering many diverse input features, but they do not consider the 
domain knowledge. Thus, it is difficult to interpret the results that are learned from training data. 
Additionally, experimental biases [14,15] may be unintentionally learned by the model parameters, 
which makes a reliable test prediction only happen for experiments with the same configuration as 
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that of training ones. In this work, we pursue the second approach, biophysical modeling, which 
produces interpretable model parameters relevant to the TF–DNA interaction mechanisms. The 
trained model parameters have clear definitions in theory. Due to such advantages, the new 
biophysical model can be adjusted and reused in different settings, and its parameter values can be 
compared between models. Many of the previous biophysical models of TF–DNA interactions do 
not consider the contribution of dinucleotide dependency in TF binding sites [13,16]. The inferred TF 
binding target motif is parameterized by a position-specific weight matrix (PWM), which is simple 
and interpretable. The independent TF binding model is often used to investigate biological 
phenomena in gene regulation. For example, a PWM-based biophysical model, BayesPI2, has been 
applied to study subtle transcription factor binding patterns and gene regulation effects in cancer 
cells [17]. Another similar program, BayesPI-BAR, has been used to predict the significance of 
mutation effects on TF–DNA binding, which led to the discovery of new regulatory mutations that 
cause gene dysregulation in follicular lymphoma [18]. 
In addition to the nucleotide sequence, local DNA structure properties, such as the geometry of 
the DNA molecule and base stacking energy, are known to affect the protein–DNA interaction [19–21]. 
Using such properties as input features together with the DNA sequence has improved TF–DNA 
binding prediction accuracy in several machine learning-based models [9,22–24]. However, until 
now, there is no biophysical model incorporating DNA structure information. Several works have 
considered general dinucleotide dependency features [3,11,12], which implicitly contain DNA shape 
information [22]. The results have been modest, with some evidence showing that the dinucleotide 
dependency models do not generalize well to in vivo data [25]. Here, we have developed a new 
biophysical model that considers DNA structure features as a special form of position-specific 
dinucleotide dependency. This model has its parameters restricted to a space defined by the 
dinucleotide combination of DNA structure properties derived from the DiProDB database [26]. We 
compare the performance of the independent PWM model, the full dinucleotide model and the DNA 
shape-restricted dinucleotide model on several tasks such as single nucleotide variant (SNV) effect 
analysis, which requires accurate TF binding affinity prediction. Unlike the machine learning 
approaches, the new biophysical model equipped with interpretable model parameters and the 
training structure, the inferred shape feature preferences can be further studied in various 
conditions. It gives us an opportunity to investigate the dynamical change of DNA shape preferences 
in different cancer cell lines. 
2. Materials and Methods 
2.1. ChIP-Seq Data 
The ChIP-seq data used to fit the TF–DNA binding affinity models was downloaded from the 
Encyclopedia of DNA Elements (ENCODE) project [27]. We use peaks from the uniform peak calling 
pipeline. The ERα (Estrogen Receptor Alpha) time series ChIP-seq is obtained from Gene Expression 
Omnibus (GEO), Accession GSE94023. FOXA1 ChIP-seq for different conditions is obtained from 
[28] (GEO Accession GSE72249). We take up to 1000 peaks with the highest signal value from each 
experiment, and for each peak, a 100 bp sequence centered on the called peak is extracted from the 
hg19 reference genome. These sequences form the positive set of samples, which are assumed to 
frequently contain the binding motif for the corresponding TF. To fit an affinity model, our methods 
also need a set of negative samples. This set consists of 100 bp sequences taken randomly from 
genome regions near transcription start sites (TSS) of known genes (TSS ± 10 kbp). The peak regions 
are excluded from the negative set, and the number of sequences in each negative set is the same as 
the size of the positive set. 
2.2. Allele-Specific Binding Data 
The dataset of allele-specific TF binding events was downloaded from a recent publication [29]. 
It was derived from raw reads of ENCODE ChIP-seq experiments for 36 TFs in several cell lines, 
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where SNVs were first identified and then assessed for possible allele-specific binding based on the 
number of reads containing each variant.  
2.3. BayesPI Transcription Factor–DNA Binding Affinity Model 
The basic biophysical model of TF–DNA binding affinity, called BayesPI, was first presented  
in [13] and later extended in [3] to include the contribution of interactions between neighboring 
nucleotides in the DNA. The expression for the probability of TF binding to a small DNA segment is: 
𝑃(𝑆,𝑤, 𝜇) = ∑
1
1 + 𝑒𝐸(𝑆𝑖:𝑖+𝑀,𝑤)−𝜇
𝑁−𝑀
𝑖=0
 
where 𝑆𝑖,𝑎 = 1 if the DNA sequence has nucleotide 𝑎 (one of A, C, G, T) at position 𝑖 and 𝑆𝑖,𝑗 = 0 
otherwise, 𝑁  is the sequence length, 𝑀  is the length of the binding motif (the number of 
consecutive base pairs that affect the affinity), and 𝜇 is the chemical potential of the TF, which is 
defined by its concentration in the nucleus. The binding energy of the TF to a short DNA fragment 
with length 𝑀 bp is represented by 𝐸, which is the sum of the independent contributions of each 
nucleotide: 
𝐸𝑖𝑛𝑑𝑒𝑝(𝑆, 𝑤) = ∑ ∑𝑤𝑗,𝑎𝑆𝑗,𝑎
4
𝑎=1
𝑀−1
𝑗=0
 
The matrix 𝑤 ∈ ℝ𝑀×4, called the position-specific affinity matrix, specifies these contributions: 
𝑤𝑗,𝑎 is the binding energy of nucleotide 𝑎 at position 𝑗 inside the DNA fragment. The protein 
binding energy may consider the contribution of dinucleotide dependence: 
𝐸𝑑𝑖𝑛𝑢𝑐(𝑆, 𝑑) = ∑∑∑𝑑𝑗,(𝑎−1)∗4+𝑏𝑆𝑗,𝑎𝑆𝑗+1,𝑏
4
𝑏=1
4
𝑎=1
𝑀−2
𝑗=0
 
where 𝑑 ∈ ℝ𝑀−1×16  is the matrix of pairwise dependency energy correction, with 𝑑𝑗,(𝑎−1)∗4+𝑏 
specifying the correction of the independent energy terms for the dinucleotide at positions 𝑗: 𝑗 + 1 
with nucleotides 𝑎 and 𝑏. 
2.4. DNA Shape Affinity Model 
The TF–DNA binding affinity model that takes into account DNA shape information includes 
dinucleotide dependencies in a more structured form, following prior information about DNA 
molecule characteristics, which may be important for the protein–DNA interaction. The affinity is 
modeled as: 
𝑃(𝑆, 𝐹, 𝑤, 𝑑𝑓 , 𝜇) = ∑
1
1 + 𝑒𝐸𝑖𝑛𝑑𝑒𝑝(𝑆𝑖:𝑖+𝑀,𝑤)+𝐸𝑠ℎ𝑎𝑝𝑒(𝐹𝑖:𝑖+𝑀,𝑑
𝑓)−𝜇
𝑁−𝑀
𝑖=0
 
where 𝐹 ∈ ℝ𝑀×𝐾 is the matrix of DNA shape feature values at each position inside the sequence 𝑆 
and 𝐾 is the number of different DNA shape features considered. 𝐹𝑖,𝑗 is the value of DNA shape 
feature 𝑗 at position 𝑖, which is a number characterizing a certain property of the DNA molecule at 
that location. Analogous to the independent and dinucleotide models, DNA shape contributes 
linearly to the binding energy: 
𝐸𝑠ℎ𝑎𝑝𝑒(𝐹, 𝑑
𝑓) = ∑ ∑𝑑𝑗,𝑘
𝑓 𝐹𝑗,𝑘
𝐾
𝑘=1
𝑀−1
𝑗=0
 
where 𝑑𝑓 ∈ ℝ𝑀×𝐾 is the matrix of position-specific DNA shape preference of the TF, expressed as a 
correction to the independent nucleotide preferences. The 2–mer shape features used in this work 
Genes 2017, 8, 233  4 of 15 
 
come from the DiProDB database [26], which lists thermodynamic, structural and some other 
properties of DNA and RNA dinucleotides. We use four features: twist, minor groove width, 
propeller twist and roll. These features are chosen following an earlier DNA shape publication [30], 
where the same DNA shape characteristics are used in TF–DNA affinity modeling. However, the 
DNA shape features in [30] are based on 5– and 6–mer sequences, while DiProDB uses 
dinucleotides only. In the dinucleotide case, 𝐹 can be expressed as:  
𝐹𝑗,𝑘 =∑∑𝐷𝑘,(𝑎−1)∗4+𝑏𝑆𝑗,𝑎𝑆𝑗+1,𝑏
4
𝑏=1
4
𝑎=1
 
where 𝐷 ∈ ℝ𝐾×16 is the matrix of 𝐾 DNA shape feature values for each dinucleotide. In our 
model, 𝐾 = 4. Plugging the expression for 𝐹 into the definition of 𝐸𝑠ℎ𝑎𝑝𝑒, we observe that, as it is 
defined here, the DNA shape energy contribution 𝐸𝑠ℎ𝑎𝑝𝑒  and the dinucleotide dependency energy 
contribution 𝐸𝑑𝑖𝑛𝑢𝑐  are linearly related: 
𝐸𝑠ℎ𝑎𝑝𝑒(𝐹, 𝑑
𝑓) = 𝐸𝑑𝑖𝑛𝑢𝑐(𝑆, 𝑑
𝑓 ∙ 𝐷) 
In other words, the DNA shape model is a dinucleotide dependency model whose coefficients 
are restricted to a linear subspace spanned by the shape features 𝐷. This is a useful property that 
allows efficient computation of affinity without the need to compute DNA shape features explicitly 
for each sequence. Furthermore, any software that works with dinucleotide models, such as 
BayesPI2, can now be used to work with DNA shape models by expanding 𝑑𝑓 coefficients into full 
dinucleotide coefficients 𝑑 = 𝑑𝑓 ∙ 𝐷.  
2.5. Bayesian Inference of Model Parameters for the DNA Shape Restricted Dinucleotide Dependence Model 
The parameters of TF–DNA affinity models (𝑤, 𝜇 and 𝑑𝑓) are fitted to the experimental data, 
such as ChIP-seq peaks or protein binding microarray probes, using gradient descent, starting from 
a randomized initial seed. Because the experimental data typically contain measurement noise, a 
proper regularization of the model is important [31]. This is done by applying Bayesian inference to 
the L2 regularization hyperparameters, hence the name BayesPI. The Bayesian inference proceeds 
in iterations of sequential estimation of model parameters, such as 𝑤 , 𝜇  and 𝑑𝑓 , and 
hyperparameters, which are L2 regularization coefficients 𝛼𝑖 and the error scaling coefficient 𝛽. 
When fitting the model parameters, the gradient descent is performed on the following regularized 
cost function: 
𝐿 = 𝛽𝐿𝐷(𝑤, 𝑑
𝑓 , 𝜇, 𝑎, 𝑏) +∑𝛼𝑖𝑊𝑖
2
𝑖
 
𝐿𝐷(𝑤, 𝑑
𝑓 , 𝜇, 𝑎, 𝑏) =
1
2
∑((𝑎 ∙ 𝑃(𝑆𝑖, 𝑤, 𝜇, 𝑑
𝑓) + 𝑏) − 𝑡𝑖)
𝑖
2
 
where 𝑡𝑖 is the target value (e.g., normalized ChIP-seq tag count) for sequence 𝑆𝑖, 𝑎 and 𝑏 are 
coefficients of the linear transformation applied to the binding probability in order to match its 
distribution to the distribution of 𝑡𝑖 and 𝑊 is the sequence of all model parameters: 𝑤, 𝑑
𝑓 , 𝜇, 𝑎 
and 𝑏. On the first iteration, the regularization hyperparameters 𝛽 and 𝛼𝑖 are set to constant 
values corresponding to a weak regularization. After the gradient descent has converged, the 
hyperparameter values are updated using the following formulas: 
𝛼𝑖 =
𝛾𝑖
𝑊𝑖
2 
𝛽 =
𝑁 − ∑ 𝛾𝑖𝑖
2𝐿𝐷
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𝛾𝑖 = 1 − 𝛼𝑖𝐻𝑖𝑖
−1 
where 𝑁 is the number of sequences and 𝐻 = 𝐽(∇𝐿)T is the Hessian matrix of the cost function, 
evaluated at the converged values of model parameters, and 𝐽 is the Jacobian matrix (see the 
Supplementary Methods for the formulas to compute the Hessian). Since 𝛾𝑖 and 𝐻 depend on 𝛽 
and 𝛼𝑖, the hyperparameter update is also performed iteratively, repeatedly recomputing values of 
𝛾𝑖  and 𝐻 , followed by recomputation of 𝛽  and 𝛼𝑖 , until convergence. The values of model 
parameters 𝑊 are kept fixed during the hyperparameter update computation. 
After the hyperparameters have been updated, we again perform the gradient descent on the 
model parameters, starting from their values on the previous iteration. The whole process is 
repeated several times, usually converging in 3–10 iterations. The derivation of this algorithm, 
based on Bayesian treatment of the uncertainty of the hyperparameters, is given in [32]. In BayesPI, 
the 𝛼𝑖 hyperparameters are grouped together and their values shared between classes. All weights 
of the independent part of the model, 𝑤, share a single 𝛼𝑤 (please refer to the Supplementary 
Methods for computational details of this procedure). The dinucleotide DNA shape feature weights 
at the same position 𝑝, 𝑑𝑝,𝑘
𝑓
 also share the same regularization weight 𝛼𝑑,𝑝. The reason is that the 
information content of the motif is distributed unequally across positions, with some positions 
being important while others affecting the affinity weakly. To avoid the overfitting of larger shape 
model parameters, they should be more strongly regularized at unimportant positions. This is 
achieved automatically by the Bayesian regression procedure. Since all dinucleotide weights at the 
same position share a single hyperparameter value, they will all be regularized with the same 
strength. Position-based regularization allows restricting the dependency parameters at positions 
where the dependency does not seem to contribute to the affinity, while letting the parameters 
grow at more important positions. The model is typically fit in two stages: first, the independent 
parameters 𝑤 are fit, setting 𝑑𝑓 = 0. Then, 𝑤 is fixed, and the dependent parameters 𝑑𝑓 are fit. 
Thus, the dinucleotide shape-restricted dependency parameters 𝑑𝑓  should be viewed as 
adjustments of the independent model, in places where dependencies are significant. 𝑑𝑓 = 0 
recovers the original independent model. 
2.6. Mutation Effect Prediction by Using Various Biophysical Models 
We use the BayesPI-BAR [4] method to evaluate how a DNA variant affects TF binding. 
BayesPI-BAR computes a score called shifted differential binding affinity (𝛿𝑑𝑏𝐴) for each variant 
and TF. 𝛿𝑑𝑏𝐴  measures the difference in above-background binding strength between the 
reference and alternate sequences, which is equivalent to measuring the effect of the sequence 
variant on TF binding. If 𝛿𝑑𝑏𝐴 > 0, then there is an increase of TF binding affinity in the alternate 
sequence compared to that in the reference sequence: creation of a new TF binding site or 
strengthening of an existing weak binding site. If 𝛿𝑑𝑏𝐴 < 0, then an existing TF binding site is 
disrupted by the variant. In the previous works, we only considered the independent binding 
affinity model for TFs in BayesPI-BAR. Here, we use independent, full dinucleotide dependence, 
and newly-developed DNA shape-restricted dinucleotide dependence models to evaluate the 
prediction of the mutation effect in cancer cells. 
2.7. Code Availability 
The new BayesPI2Shape software contains independent, dinucleotide dependence, and DNA 
shape-restricted dinucleotide dependence models (preselected DNA shape features and the 
visualization function) are available from http://folk.uio.no/junbaiw/bayesPI2shape/.  
3. Results 
3.1. Validation of Inferred DNA Shape Feature Preferences for Protein–DNA Interaction 
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The main advantage of the new shape-restricted TF–DNA affinity model is the interpretability 
of the model parameters. The matrix 𝑑𝑓 models the adjustments of the binding energy, due to the 
preferred DNA shape feature at a specific TF binding position: a positive value of 𝑑𝑗,𝑘
𝑓  indicates 
that the higher the values of shape feature 𝑘 at position 𝑗, the higher the TF binding affinity; but a 
negative value indicates that a low value of shape feature is preferred at the TF binding position. 
Thus, we call 𝑑𝑓 the (DNA) shape preference matrix. To validate the fitted shape preferences, we 
tested the new method on three TFs (Serum Response Factor (SRF), Myocyte Enhancer Factor 2C 
(MEF2C), and TATA-Box Binding Protein (TBP)) for which the DNA shape preferences were 
previously reported. In this test, we use PWMs from JASPAR and fit only 𝑑𝑓 using the ChIP-seq 
datasets from ENCODE. In Figure 1A, a heatmap of the shape feature preferences of SRF is shown. 
The most pronounced shape feature preference is for higher propeller twist at position 6, which 
matches the findings in [9]. The exact position may be shifted a few base pairs compared to Figure 7 
in [9], because 5– and 6–mer DNA shape features are used in the previous work, while we use only 
dinucleotide shape features. 
 
Figure 1. Shape feature preferences for Serum Response Factor (SRF), Myocyte Enhancer Factor 2C 
(MEF2C), and TATA-Box Binding Protein (TBP). The heatmaps show the preference for each shape 
feature at each binding position (the inferred 𝑑𝑓 matrix), with the preference for low and high 
feature values in blue and orange, respectively. The shape preferences are split into positive and 
negative parts accordingly. Grey color represents weaker preference. The position-specific weight 
matrix (PWM) logos of transcription factors (TFs) are shown above the shape preference heatmaps. 
In Figure 1B, the heatmap for MEF2C is shown, where propeller twist and roll have strong 
preferences in the current prediction. The two shape features are also the most important features for 
MEF2C reported in [9], although their locations and strength are slightly different. It is noteworthy 
that in [9], the relative feature importance score given by the random forest model was used to 
predict DNA shape feature preferences. This score cannot be compared across different models. On 
the other hand, our biophysically-modeled DNA shape preferences 𝑑𝑓  directly reflect the 
dynamical modification of TF binding affinities in the change of DNA shape features. In Figure 1C, 
our predicted TBP shape feature preferences are shown, where minor groove width is the main 
dependency term. The result is consistent with the fact that TBP recognizes its target sequence by 
binding to the minor groove [33]. 
3.2. ChIP-Seq Peak Prediction 
Here, we evaluate the performance of three affinity models (the independent model, the full 
dinucleotide model and the DNA shape-restricted dinucleotide model) to predict ChIP-seq peaks, 
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using the ENCODE data. First, three independent models with motif sizes of 10, 15 and 20 were 
fitted for each of 36 TFs. We retain only the models that fit the training data well: r2 of prediction for 
the raw signal is greater than 0.4, the area under receiver operating characteristic curve (AUC) >0.75 
for distinguishing true peak sequences from the background ones. Then, we fit the dinucleotide 
interaction models and DNA shape models as corrections to the independent models on the same 
training data. The prediction results on an independent test set are shown in Figure 2. The AUC of 
each independent model is plotted against the AUC of the same model with a dependency 
correction. Both the dinucleotide dependent and the DNA shape-restricted models improve the 
accuracy of peak prediction significantly, which are compared to that by the independent model. In 
the current study, the full dinucleotide model (Figure 2A) usually has much higher accuracy than 
the DNA shape model (Figure 2B). The improvement of TF binding motif prediction by using the 
nucleotide dependent models (e.g., dinucleotides, k-mers and DNA shape features), on a 
homogeneous dataset such as ChIP-seq or protein binding microarray data, has been demonstrated 
before with black box machine learning techniques [9,12,25]. Here, we show that it also holds true for 
the new biophysical model. Figure 2 indicates that the full dinucleotide model is superior to the DNA 
shape-restricted dinucleotide model. However, such outcomes need to be considered with caution. 
That is because an experiment such as ChIP-seq is known to contain biases in the measurements. 
These biases do not reflect the underlying true biochemical processes, but may belong to a 
systematic error from the experimental procedure. Such errors may be learned by a powerful 
machine learning method. For example, the full dinucleotide model may learn a spurious 
dependency originating from an experiment-specific bias, which leads to the model only performing 
well in data generated from the same type of experiments. To fully assess the usefulness of a new 
model, it needs to be validated by different types of experimental datasets (e.g., a model trained on 
in vivo data, but tested on in vitro data). 
 
Figure 2. ChIP-seq peaks prediction is improved in dependency of the models. For each of the 172 
ChIP-seq datasets for 36 TFs, the area under receiver operating characteristic curve (AUC) of the 
independent model is compared to (A) the full dinucleotide model, which has a separate tunable 
parameter for each of 16 possible dinucleotides at each position, and (B) the DNA shape-restricted 
dinucleotide model, which has a separate tunable parameter for each shape feature (e.g., four DNA 
shape features in the current study) at each position. 
3.3. Investigating the Variation of Predicted DNA Shape Preferences across Cell Types 
The parameters of the new DNA shape model have a straightforward interpretation, similar to 
that of the dinucleotide dependency model: each 𝑑𝑗,𝑘
𝑓  is the weight of the preference of the TF for 
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the shape feature 𝑘 at position 𝑗, in addition to that defined by the independent model weights 𝑤. 
This enables an easy comparison of fitted shape parameters between different conditions. Here, we 
explore the variation of fitted shape model parameters, across different cancer cell lines. Our model 
is based on the hypothesis that the DNA shape readout by a TF depends only on the TF itself and 
the local DNA sequence. This assumption may be violated in vivo due to epigenetic DNA 
modifications [23,34], nucleosome positioning in the DNA sequence [35] or because of the presence 
of cofactors [20]. In order to assess the influence of these external factors on the shape model fitting 
procedure, we compared shape features predicted in different cell lines and different conditions for 
the same TF. 
We use canonical PWMs from the JASPAR web database [36] for 23 TFs, where ENCODE 
ChIP-seq datasets are available for more than one cell line. For each TF, we fit the shape model 
parameters for each ChIP-seq dataset separately and compute the correlation of the fitted shape 
preference parameters between different cell lines. The distribution of the median correlation 
coefficients across TFs is shown in Figure 3A. Three of the TFs (Basic Helix-Loop-Helix Family 
Member E40 (BHLHE40,) MYC Associated Factor X (MAX), and JunD Proto-Oncogene (JUND)) 
have very low shape feature correlations between the conditions (e.g., <0.2). The PWM that we used 
for JUND has a poor performance for distinguishing the true peaks from the background ones: AUC 
is 0.58. This suggests that if the independent model cannot predict TF bindings well, then the result 
of the shape model is also unreliable. On average, the correlation of predicted shape preferences 
among different cell lines is high, with the median of them being around 0.7. The shape preference 
seems stable in in vivo conditions. In Figure 3B,C, the fitted shape feature variations in three 
conditions are given for E74 Like ETS Transcription Factor 1 (ELF1) (median correlation 0.7) and 
Upstream Transcription Factor 2 (USF2) (median correlation 0.67), respectively, where each shape 
model matrix 𝑑𝑓 is displayed by a heatmap (positive preferences). The negative preferences are 
shown in Supplementary Figures S2A,B. In Figure 4, MAX and BHLHE40 have nearly identical 
PWMs with very pronounced 6 bp core motifs, and the independent parts of the binding affinity 
models are very similar, though the inferred shape preferences for MAX and BHLHE40 differ 
significantly across cell lines (see Supplementary Figure S1 for the positive shape preferences). Thus, 
the predicted shape preferences may be used to distinguish the true binding sites between MAX and 
BHLHE40. 
 
Figure 3. Shape model parameters in different conditions. (A) Distribution of median correlation 
coefficients for 23 TFs with multiple ChIP-seq datasets. (B) Shape feature preferences for ELF1 in 
three cell lines. The heatmaps show the preference for each shape feature at each position (the 
inferred 𝑑𝑓 matrix). Only the positive preferences are shown, that is, the preferences towards higher 
values of shape features. Colors faded to grey mean weaker preference. (C) Shape feature 
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preferences for USF1 in three cell lines. The PWM logos are shown above the predicted shape 
preference heatmaps. 
 
Figure 4. Predicted shape preferences of MYC Associated Factor X (MAX) and Basic 
Helix-Loop-Helix Family Member E40 (BHLHE40) in three cell lines. The heatmaps show the 
preference for each shape feature at each position (the inferred 𝑑𝑓  matrix). Only the negative 
preferences are shown here, that is the preferences towards lower values of shape features. Colors 
faded to grey mean weaker preference. The PWM logos are shown above the shape preference 
heatmaps. 
3.4. Variation of DNA Shape Preferences across Cellular Conditions 
Changing cellular conditions may result in changing gene expression, which is caused by 
fine-tuning of TF–DNA interaction patterns. This adjustment is tightly controlled and thus may be 
reflected in the DNA shape feature preferences of affected TFs. Our new model allows identifying 
such changes by inferring shape preferences from ChIP-Seq data with different conditions. Here, we 
test the new model on the estradiol (E2)-treated MCF7 breast cancer cell line. It has been observed 
that the response of treatment includes chromatin reorganization [37], which prompts the 
investigation of possible DNA shape preference changes in the TFs involved. We used two public 
ChIP-seq datasets (GEO GSE94023 and GSE72249 [28]) to study this system. In Figure 5A (and 
Supplementary Figure S3A for negative preferences), the evolution of shape preferences of estrogen 
receptor  (ERα/ESR1) is shown at different time points after the treatment of MCF7 cells with E2. 
After E2 stimulation, ERα enters the nucleus and binds to specific sequences in the DNA called 
estrogen response elements. The shape preferences of ERα remain relatively stable across time. After 
320 minutes, the shape preference becomes weak, likely due to reduced signal as there are much 
fewer strong peaks.  
FOXA1 is a pioneer factor, that is it can bind to condensed chromatin and make it accessible to 
other TFs. As such, it must be precisely targeted to particular DNA sequences. It is known that its 
binding patterns are affected by the presence of other TFs, in particular ER and the glucocorticoid 
receptor (GR) [28]. These interactions are critically important for tumorigenesis of breast and 
prostate cancers [38]. Thus, it is interesting to see whether the change of FOXA1 binding affinity can 
be observed in the DNA shape preferences or not. In Figure 5B (see Supplementary Figure S3B for 
positive preferences), the inferred shape preferences of FOXA1 are shown in three conditions of 
MCF7 cells: untreated, treated with dexamethasone (Dex, a glucocorticoid) and treated with E2. 
Shape preferences in both treated conditions are similar to each other and slightly different from that 
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in the untreated condition, with additional preferences appearing at dinucleotide 8. This indicates 
that the modulation of FOXA1 binding by ER and GR involves changes of DNA shape. 
 
Figure 5. Condition-specific DNA shape preferences in protein-DNA interaction. (A) Variation of 
inferred shape preferences of ERα at different time points after the treatment with estradiol (E2) in 
the MCF7 cell line. (B) Variation of inferred shape preferences of FOXA1 after the treatment with 
either dexamethasone (Dex) or E2 in the MCF7 cell line. The heatmaps show the preference for each 
shape feature at each position (the inferred 𝑑𝑓 matrix). Only the positive preferences are shown  
in (A), and only the negative preferences are shown in (B). Colors faded to grey mean weaker 
preference. The PWM logos are shown above the shape preference heatmaps. 
3.5. Allele-Specific Binding Prediction 
We used the BayesPI-BAR algorithm to study whether the prediction of TF binding affinity 
changes is affected by SNVs. The SNVs used in this study were inferred from the ChIP-seq data, by 
analyzing the raw reads for the presence of allele-specific binding (ASB) events [29]. There are 36 
datasets, one per TF, with SNVs that are marked as either “ASB” (the TF binding is affected by the 
SNV) or “non-ASB” (no significant effect is observed). The task is to predict whether an SNV causes 
ASB or not, given the reference and alternate DNA sequence. BayesPI-BAR can solve the problem by 
predicting the TF binding affinity change between the two sequences with the known TF affinity 
model. The higher the absolute value of the predicted change, the greater the chance of an ASB 
event. 
We first tested the accuracy of baseline PWM models. BayesPI-BAR uses several alternative 
PWMs for the same TF simultaneously, in which case the predicted 𝛿𝑑𝑏𝐴 scores for each PWM are 
averaged. We used several sets of PWMs in this test: (1) 26 PWMs from the JASPAR database, one 
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for every TF is available; (2) 129 PWMs for 28 TFs from the database of 1772 PWMs that was used in 
the original BayesPI-BAR publication; (3) 112 PWMs for 33 TFs inferred by the BayesPI2 motif 
discovery program based on ChIP-seq datasets with motif sizes of 10, 15 and 20. The results of these 
tests are shown in Figure 6. We use the area under the precision-recall curve (AUPRC) as the 
measure of prediction performance due to class imbalance in the ASB dataset. The median AUPRC 
of BayesPI-BAR is ≈0.32, which is comparable to the accuracy of other machine learning approaches 
in [29] (e.g., ≈0.35). However, it is significantly higher than a previous report in [29], where it was 
≈0.15. Such a performance discrepancy of BayesPI-BAR in the same datasets may be caused by 
misusing of principal component analysis (PCA) scores in the earlier work [29], instead of using the 
mean 𝛿𝑑𝑏𝐴 scores in the current work. 
 
Figure 6. Allele-specific binding (ASB) prediction accuracy by various models. Distribution of the 
area under the precision-recall curve (AUPRC) for predictions of ASB events, for BayesPI-BAR, 
deltaSVM and a random forest-based sequence model from [29]. The PWM sets used in BayesPI-BAR 
are: 26 PWMs from the JASPAR database; the relevant PWMs from the set of 1772 human TF PWMs 
in the original database supplied with BayesPI-BAR; a set of PWMs that could be successfully 
inferred by the BayesPI motif discovery program using the Encyclopedia of DNA Elements 
(ENCODE) ChIP-seq data. Data for models marked with a star are reproduced, approximately, from 
[29]. 
After confirming that the performance of BayesPI-BAR is satisfactory for the ASB data by 
considering the independent model only, we compared the performance between the independent 
and dependent models. For each independent model of a TF, we infer the dependency correction 
parameters (either the full dinucleotide matrix or the shape feature preferences) using ChIP-seq 
datasets. The results for the available 36 TFs are summarized in Figure 6 and Supplementary  
Figure S4. In testing the dependency models, we use the same set of independent models and add 
the dependency energy terms when they are available. However, neither the full dinucleotide 
model, nor the DNA shape-restricted model improves ASB prediction accuracy over that by the 
independent model. For example, there is a big improvement in prediction accuracy in some TFs, 
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but a negative impact on the other TFs. Thus, there is no advantage of using dependent models for 
ASB event prediction in the current study.  
4. Discussion 
We have developed a new biophysical TF–DNA interaction model that takes into account DNA 
shape-restricted dinucleotide dependencies. The new model restricts the parameter space of the 
dinucleotide dependencies to a reduced subspace, which considers only the dinucleotide DNA 
shape properties. Such an implementation makes the model biophysically interpretable and can be 
used to investigate the TF–DNA interaction mechanism in various circumstances, by examining the 
predicted model parameters. It has been previously reported that models including nucleotide 
dependency parameters can fit datasets (e.g., in protein binding microarray probes, systematic 
evolution of ligands by exponential enrichment (SELEX) sequences and ChIP-seq peaks) better than 
the independent models. However, the question of whether the learned dependency features 
represent the actual TF binding preference or capture a subtle bias of an experimental error remains 
open. In the DREAM5 (TF-DNA Motif Recognition Challenge) [25], the biophysical models 
including dinucleotide interactions generally have better performance than the independent ones, 
when tested on the same type of data such as the in vitro experiment that was used for both training 
and testing data. On the contrary, the relative ranking of the independent and the dependent models 
is the opposite when models were trained on in vitro datasets, but tested on in vivo ones. Such a 
problem is later shown to be solved by a new dinucleotide model (FeatureREDUCE), by using a 
refined regularization optimization procedure [11]. However, the conclusion of FeatureREDUCE is 
based only on one TF. 
Here, we have used ChIP-seq datasets to fit dinucleotide dependency models by a Bayesian 
regression procedure, which aims to robustly estimate the model parameters when the input data 
contain noise. The use of in vivo data for training enables the models to infer the model parameters 
based on true conditions of TF–DNA binding. For the new shape model, we have compared the 
inferred shape preferences of a few TFs to that of previously-reported results, which has a 
reasonable match between the two (Figure 1). The new biophysical model with DNA shape 
preference features improves the accuracy of ChIP-seq peak prediction, when compared to the 
baseline independent model (Figure 2). We also looked into the issue of whether DNA shape 
preferences are largely independent of the cell types or not, by testing the new DNA shape model in 
ENCODE ChIP-seq data under various cell lines (Figure 3). In some cases, the inferred shape 
preferences changed between the conditions such as MAX and BHLHE40 TFs (Figure 4). The 
aforementioned two TFs can bind DNA either individually or as heterodimers with other TFs 
[39,40], which may explain the variability of the shape preferences under different conditions. 
Although the core PWM models of MAX and BHLHE40 are very similar, their predicted shape 
preferences are quite different, which may be used to distinguish the true binding target sites. This is 
a very interesting observation.  
Next, we explored the possibility of the dynamical change of DNA shape preferences in TF–
DNA interactions under various conditions, such as the response of MCF7 breast cancer cells to 
steroid treatment. In the current work, the inferred shape preferences of ERα have little change at 
different time points after the E2 treatment, except for the last few time points where the number of 
ChIP-seq peaks is reduced significantly (Figure 5A). Nevertheless, FOXA1 gained new DNA shape 
dependencies after E2 treatment, and the same additional shape dependencies are also observed 
after treatment with Dex (Figure 5B). Thus, the target binding sites of FOXA1 have slightly different 
DNA shape preferences, which indicates TF cofactors are involved in the FOXA1 binding and may 
influence the DNA geometry differently during the interaction between ER, GR and FOXA1. The 
new shape model gives us an opportunity to study in detail the intricate TF–DNA interaction 
patterns and to find a possible role of DNA shapes in different genome regulations.  
Finally, we used the BayesPI-BAR framework to assess the power of the DNA shape model in 
predicting genomic mutation effects. It was tested on an ASB dataset derived from ENCODE 
ChIP-seq data, in which the BayesPI-BAR with various nucleotide dependency models performed 
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reasonably well (Figure 6). It is worth noting that a clear understanding of the in silico prediction 
program is needed before applying it on any computational biology problems. For example, based 
on the same ASB data, a previous study reported a much lower prediction accuracy of BayesPI-BAR 
than that of the machine learning methods [29], although our reanalysis shows that BayesPI-BAR 
achieves a similar accuracy as the other methods (Figure 6). This is because the authors of [29] might 
have used a post-processed TF ranking score (principal component scores, PCA) as the indicator of 
effect size (TF binding affinity changes). Here, we used the mean 𝛿𝑑𝑏𝐴  (differential binding 
affinity) as a direct measure of TF binding changes, which correctly represents the TF binding data. 
The 𝛿𝑑𝑏𝐴 can be reused in the testing set or be compared between different conditions, but this is 
not the case for PCA scores. Nevertheless, the proposed new shape model did not, on average, 
improve the prediction accuracy of the mutation effect on TF-DNA binding over that of the 
independent model, as evidenced by ASB data. This may be due to the limitation of the present model 
(e.g., BayesPI-BAR does not consider the geometry changes of the DNA molecule when it is wrapped 
around a nucleosome).  
Generally, nucleosome core particles interact with the DNA, bending it nonuniformly and in a 
sequence-dependent manner, which affects the DNA shape features [35]. The DNA shape features 
in turn may influence the preferential location of nucleosomes [41]. These interdependencies 
between the DNA shape and nucleosomes, the dynamic positioning of nucleosomes, the TF-specific 
interaction with nucleosomes and the lack of true information on nucleosome positions make it 
difficult to build a biophysical model with the consideration of the nucleosome effects in the  
TF–DNA interaction. Thus, the nucleosome-related adjustments to the DNA shape are treated as 
noise in the current model; a future study to overcome this limitation by considering more genomic 
data and a refined model shall be carried out. Especially, more systematic investigation is needed to 
access the contribution of DNA shape in regulatory mutation studies. 
In conclusion, the new DNA shape enhanced biophysical model enables the investigation of 
additional aspects of TF–DNA binding. Given the encouraging results in ChIP-seq peak prediction, a 
further development of the nucleotide dependency models, including the DNA shape preferences 
model, is a promising direction for future research. Such models, which can substantially improve 
the prediction accuracy of mutation effects, will lead to a better understanding of mutation-induced 
genome dysregulation in diseases such as cancer. 
Supplementary Materials: The following are available online at www.mdpi.com/2073-4425/8/9/233/s1.  
Figure S1: Fitted shape preferences of MAX and BHLHE40 for different cell lines (positive part). Figure S2: 
Shape model parameters in different conditions (negative part). Figure S3: Changes in shape preferences. Figure 
S4: ASB prediction of the full dinucleotide and shape-restricted models compared to the independent model. 
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